| Authors: |
Burman RJ; Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom.; Oxford Epilepsy Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, United Kingdom., Diviney T; Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom., Călin A; Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom., Gothard G; Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom., Jouhanneau JM; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin 13125, Germany.; Neuroscience Research Center, Charité-Universitätsmedizin, Berlin 10117, Germany., Poulet JFA; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin 13125, Germany.; Neuroscience Research Center, Charité-Universitätsmedizin, Berlin 10117, Germany., Sen A; Oxford Epilepsy Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, United Kingdom., Akerman CJ; Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom colin.akerman@pharm.ox.ac.uk. |
